Results 21 to 30 of about 798,093 (282)

Clinical aspects of severe cutaneous adverse reactions caused by beta-lactam antibiotics: A study from the Korea SCAR registry

open access: yesWorld Allergy Organization Journal, 2023
Background: Although beta-lactams are 1 of the major causative agents of severe cutaneous adverse reactions (SCAR), their epidemiology and clinical aspects have been poorly studied.
Min-Hye Kim, MD, PhD   +16 more
doaj   +1 more source

Synergy Between Beta-Lactams and Lipo-, Glyco-, and Lipoglycopeptides, Is Independent of the Seesaw Effect in Methicillin-Resistant Staphylococcus aureus

open access: yesFrontiers in Molecular Biosciences, 2021
Methicillin-resistant S. aureus (MRSA) are resistant to beta-lactams, but synergistic activity between beta-lactams and glycopeptides/lipopeptides is common.
Rutan Zhang   +9 more
doaj   +1 more source

Which Are the Best Regimens of Broad-Spectrum Beta-Lactam Antibiotics in Burn Patients? A Systematic Review of Evidence from Pharmacology Studies

open access: yesAntibiotics, 2023
Background: Burn injury causes profound pathophysiological changes in the pharmacokinetic/pharmacodynamic (PK/PD) properties of antibiotics. Infections are among the principal complications after burn injuries, and broad-spectrum beta-lactams are the ...
Gianpiero Tebano   +6 more
doaj   +1 more source

Characterization and molecular epidemiology of Staphylococcus aureus strains resistant to beta-lactams isolated from the milk of cows diagnosed with subclinical mastitis [PDF]

open access: yesVeterinary World, 2019
Background and Aim: The term ESKAPE, recognized by the WHO, is an acronym, which refers to the pathogens Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp., which is ...
Geziella Áurea Aparecida Damasceno Souza   +6 more
doaj   +1 more source

Triple oral beta-lactam containing therapy for Buruli ulcer treatment shortening. [PDF]

open access: yesPLoS Neglected Tropical Diseases, 2019
The potential use of clinically approved beta-lactams for Buruli ulcer (BU) treatment was investigated with representative classes analyzed in vitro for activity against Mycobacterium ulcerans.
María Pilar Arenaz-Callao   +5 more
doaj   +1 more source

β-Lactams from the Ocean

open access: yes, 2023
The title of this essay is as much a question as it is a statement. The discovery of the β-lactam antibiotics—including penicillins, cephalosporins, and carbapenems—as largely (if not exclusively) secondary metabolites of terrestrial ...
Jed F. Fisher, Shahriar Mobashery
core   +1 more source

Uncovering Beta-Lactam Susceptibility Patterns in Clinical Isolates of Mycobacterium tuberculosis through Whole-Genome Sequencing [PDF]

open access: yes, 2022
The increasing threat of drug resistance and a stagnated pipeline of novel therapeutics endanger the eradication of tuberculosis. Beta-lactams constitute promising additions to the current therapeutic arsenal and two carbapenems are included in group C ...
Olivença, Francisco   +8 more
core   +1 more source

Disparities in antimicrobial consumption and resistance within a country: the case of beta-lactams in Argentina

open access: yesRevista Panamericana de Salud Pública, 2021
Objective. To describe bacterial resistance and antimicrobial consumption ratio at the subnational level in Argentina during 2018, considering beta-lactams group as a case-study. Methods.
Silvia Boni   +8 more
doaj   +1 more source

Patterns and outcomes of empirical antimicrobial use in elderly outpatients: A pilot observational study from North India

open access: yesJournal of the Indian Academy of Geriatrics, 2022
Introduction: Despite the rampant use of antimicrobials in health-care settings, the safety and clinical outcome data of antimicrobials are scarce in the elderly population.
Bisweswar Ojha   +3 more
doaj   +1 more source

Comparison of combination therapy with beta-lactam and aminoglycoside antibiotics versus monotherapy with beta-lactam antibiotics on clinical outcomes in adult sepsis patients at RSUP Dr. Kariadi in Semarang [PDF]

open access: yesBIO Web of Conferences
Sepsis is a complex clinical syndrome resulting from the body’s systemic response to an infection that causes organ dysfunction and requires treatment with broad-spectrum antibiotics. Beta-lactams are broad-spectrum antibiotics used either as monotherapy
Dilaga Arroyani Asa   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy